• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

晚期囊性纤维化肺病患者心肺运动试验得出的次最大运动结果的可行性及报告者间变异性

Feasibility and inter-reporter variability of submaximal outcomes derived from cardiopulmonary exercise testing in people with advanced cystic fibrosis lung disease.

作者信息

Urquhart Don S, Jamieson Patrick, Burns Paul, Braun Julia, Hebestreit Helge, Radtke Thomas

机构信息

Department of Paediatric Respiratory and Sleep Medicine, Royal Hospital for Children and Young People, Edinburgh, UK.

Department of Child Life and Health, University of Edinburgh, Edinburgh, UK.

出版信息

ERJ Open Res. 2025 Jun 30;11(3). doi: 10.1183/23120541.01001-2024. eCollection 2025 May.

DOI:10.1183/23120541.01001-2024
PMID:40589908
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12208563/
Abstract

BACKGROUND

Cardiopulmonary exercise testing (CPET) provides prognostic information in people with advanced cystic fibrosis lung disease (pwACFLD). This project aimed to ascertain feasibility and inter-reporter variability in the identification of submaximal CPET outcomes for pwACFLD as potential predictors of prognosis where no peak exercise data are available.

METHODS

We utilised data from an international retrospective multicentre study involving pwACFLD, for whom raw CPET data were available. Two experienced operators independently reviewed and analysed CPET tests with a focus on three pre-defined measures: oxygen uptake (' ) at the anaerobic threshold (AT), the breathing reserve index at the AT (BRIAT), and the slope of the minute ventilation to carbon dioxide production ratio ('/' -slope). We calculated intra-class correlation coefficients (ICCs) with their 95% confidence intervals (CI), and limits of agreement using the Bland-Altman method.

RESULTS

The original cohort included 174 pwACFLD. Among those, raw CPET data were available for 101 individuals, of which 89 tests were of sufficient technical quality for submaximal analysis. In 72 out of 89 technically acceptable tests (81%), the AT could be confidently identified by both operators. Furthermore, ICCs indicated good-to-excellent inter-reporter agreement for ' at the AT (ICC 0.79, 95% CI 0.62-0.88), the '/' -slope (0.95, 95% CI 0.93-0.97) and BRIAT (0.76, 95% CI 0.63-0.85).

CONCLUSIONS

Submaximal CPET data can be reliably obtained in most pwACFLD by trained CPET operators. Future studies may ascertain the prognostic value of submaximal CPET outcomes in pwACFLD.

摘要

背景

心肺运动试验(CPET)可为晚期囊性纤维化肺病患者(pwACFLD)提供预后信息。本项目旨在确定在无峰值运动数据的情况下,识别pwACFLD次极量CPET结果作为预后潜在预测指标的可行性和报告者间的变异性。

方法

我们利用了一项涉及pwACFLD的国际回顾性多中心研究的数据,这些患者有原始的CPET数据。两名经验丰富的操作人员独立审查和分析CPET测试,重点关注三个预先定义的指标:无氧阈(AT)时的摄氧量( )、AT时的呼吸储备指数(BRIAT)以及分钟通气量与二氧化碳产生量比值的斜率( / 斜率)。我们计算了组内相关系数(ICC)及其95%置信区间(CI),并使用Bland - Altman方法计算一致性界限。

结果

最初的队列包括174名pwACFLD患者。其中,101名个体有原始CPET数据,其中89次测试的技术质量足以进行次极量分析。在89次技术上可接受的测试中,有72次(81%)两名操作人员都能可靠地识别出AT。此外,ICC表明报告者间在AT时的 (ICC 0.79,95% CI 0.62 - 0.88)、 / 斜率(0.95,95% CI 0.93 - 0.97)和BRIAT(0.76,95% CI 0.63 - 0.85)方面具有良好至极好的一致性。

结论

经过培训的CPET操作人员能够在大多数pwACFLD患者中可靠地获取次极量CPET数据。未来的研究可以确定次极量CPET结果在pwACFLD中的预后价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ab/12208563/87f55cd257ba/01001-2024.02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ab/12208563/16d8217acdbc/01001-2024.01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ab/12208563/87f55cd257ba/01001-2024.02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ab/12208563/16d8217acdbc/01001-2024.01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ab/12208563/87f55cd257ba/01001-2024.02.jpg

相似文献

1
Feasibility and inter-reporter variability of submaximal outcomes derived from cardiopulmonary exercise testing in people with advanced cystic fibrosis lung disease.晚期囊性纤维化肺病患者心肺运动试验得出的次最大运动结果的可行性及报告者间变异性
ERJ Open Res. 2025 Jun 30;11(3). doi: 10.1183/23120541.01001-2024. eCollection 2025 May.
2
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.社区居住的老年人跌倒预防干预措施:系统评价和荟萃分析的益处、危害以及患者的价值观和偏好。
Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3.
3
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
4
Inhaled mannitol for cystic fibrosis.吸入用甘露醇治疗囊性纤维化。
Cochrane Database Syst Rev. 2018 Feb 9;2(2):CD008649. doi: 10.1002/14651858.CD008649.pub3.
5
Non-invasive ventilation for cystic fibrosis.囊性纤维化的无创通气
Cochrane Database Syst Rev. 2017 Feb 20;2(2):CD002769. doi: 10.1002/14651858.CD002769.pub5.
6
Physical activity and exercise training in cystic fibrosis.囊性纤维化中的体力活动和运动训练。
Cochrane Database Syst Rev. 2022 Aug 9;8(8):CD002768. doi: 10.1002/14651858.CD002768.pub5.
7
Aerobic exercise interventions for adults living with HIV/AIDS.针对感染艾滋病毒/艾滋病的成年人的有氧运动干预措施。
Cochrane Database Syst Rev. 2005 Apr 18(2):CD001796. doi: 10.1002/14651858.CD001796.pub2.
8
Prognosis of adults and children following a first unprovoked seizure.首次无诱因发作后成人和儿童的预后。
Cochrane Database Syst Rev. 2023 Jan 23;1(1):CD013847. doi: 10.1002/14651858.CD013847.pub2.
9
Progressive resistive exercise interventions for adults living with HIV/AIDS.针对感染艾滋病毒/艾滋病的成年人的渐进性抗阻运动干预措施。
Cochrane Database Syst Rev. 2004 Oct 18(4):CD004248. doi: 10.1002/14651858.CD004248.pub2.
10
Incentives for preventing smoking in children and adolescents.预防儿童和青少年吸烟的激励措施。
Cochrane Database Syst Rev. 2017 Jun 6;6(6):CD008645. doi: 10.1002/14651858.CD008645.pub3.

本文引用的文献

1
Lung transplant referral considerations for individuals with cystic fibrosis.囊性纤维化患者的肺移植转诊考量因素
Curr Opin Pulm Med. 2024 Nov 1;30(6):640-645. doi: 10.1097/MCP.0000000000001111. Epub 2024 Aug 12.
2
Cardiopulmonary Exercise Testing for Prognostication in Advanced Cystic Fibrosis Lung Disease and Beyond.晚期囊性纤维化肺病及其他疾病中用于预后评估的心肺运动试验
Ann Am Thorac Soc. 2024 Mar;21(3):380-381. doi: 10.1513/AnnalsATS.202311-944ED.
3
Cardiopulmonary Exercise Testing Provides Prognostic Information in Advanced Cystic Fibrosis Lung Disease.
心肺运动试验在晚期囊性纤维化肺病中提供预后信息。
Ann Am Thorac Soc. 2024 Mar;21(3):411-420. doi: 10.1513/AnnalsATS.202304-317OC.
4
Pick Your Threshold: A Comparison Among Different Methods of Anaerobic Threshold Evaluation in Heart Failure Prognostic Assessment.选择你的阈值:心力衰竭预后评估中不同无氧阈值评估方法的比较。
Chest. 2022 Nov;162(5):1106-1115. doi: 10.1016/j.chest.2022.05.039. Epub 2022 Jun 24.
5
Inter-observer agreement of preoperative cardiopulmonary exercise test interpretation in major abdominal surgery.术前心肺运动试验解读在大型腹部手术中的观察者间一致性。
BMC Anesthesiol. 2022 Apr 30;22(1):131. doi: 10.1186/s12871-022-01680-y.
6
The importance of ventilatory thresholds to define aerobic exercise intensity in cardiac patients and healthy subjects.通气阈对确定心脏病患者和健康受试者有氧运动强度的重要性。
Scand J Med Sci Sports. 2021 Sep;31(9):1796-1808. doi: 10.1111/sms.14007. Epub 2021 Jul 5.
7
ERS statement on standardisation of cardiopulmonary exercise testing in chronic lung diseases.ERS 关于慢性肺部疾病心肺运动试验标准化的声明。
Eur Respir Rev. 2019 Dec 18;28(154). doi: 10.1183/16000617.0101-2018. Print 2019 Dec 31.
8
Reduced exercise ventilatory efficiency in adults with cystic fibrosis and normal to moderately impaired lung function.成人囊性纤维化患者,肺功能正常至中度受损,运动通气效率降低。
J Appl Physiol (1985). 2019 Aug 1;127(2):501-512. doi: 10.1152/japplphysiol.00030.2019. Epub 2019 Jun 20.
9
Cardiopulmonary Exercise Testing: Another Tool in the Prognostication Tool Kit for Cystic Fibrosis.心肺运动试验:囊性纤维化预后评估工具包中的另一种工具。
Am J Respir Crit Care Med. 2019 Apr 15;199(8):938-940. doi: 10.1164/rccm.201810-2053ED.
10
Cardiopulmonary Exercise Testing Provides Additional Prognostic Information in Cystic Fibrosis.心肺运动试验为囊性纤维化提供额外的预后信息。
Am J Respir Crit Care Med. 2019 Apr 15;199(8):987-995. doi: 10.1164/rccm.201806-1110OC.